You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 7, 2024

ZADITOR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Zaditor patents expire, and what generic alternatives are available?

Zaditor is a drug marketed by Alcon Pharma and Alcon Pharms Ltd and is included in two NDAs.

The generic ingredient in ZADITOR is ketotifen fumarate. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ketotifen fumarate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Zaditor

A generic version of ZADITOR was approved as ketotifen fumarate by APOTEX INC on May 9th, 2006.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ZADITOR?
  • What are the global sales for ZADITOR?
  • What is Average Wholesale Price for ZADITOR?
Drug patent expirations by year for ZADITOR
Drug Prices for ZADITOR

See drug prices for ZADITOR

Recent Clinical Trials for ZADITOR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sen-Jam PharmaceuticalPhase 2
National University, SingaporePhase 2
EyeMax, LLCPhase 3

See all ZADITOR clinical trials

Pharmacology for ZADITOR
Paragraph IV (Patent) Challenges for ZADITOR
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ZADITOR Ophthalmic Solution ketotifen fumarate 0.025% 021066 1 2004-12-23

US Patents and Regulatory Information for ZADITOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Pharma ZADITOR ketotifen fumarate SOLUTION/DROPS;OPHTHALMIC 021066-002 Oct 19, 2006 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alcon Pharms Ltd ZADITOR ketotifen fumarate SOLUTION/DROPS;OPHTHALMIC 077200-001 Sep 2, 2008 OTC No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.